Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Artrya Limited (AU:AYA)
ASX:AYA
Holding AU:AYA?
Track your performance easily
AYA Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.16 - AU$0.42
Previous CloseAU$0.3
Volume4.77K
Average Volume (3M)34.87K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)AU$35.56M
Total Debt (Recent Filing)AU$1.37M
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Feb 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares OutstandingN/A
10 Day Avg. Volume12,760
30 Day Avg. Volume34,874
Standard Deviation0.22
R-Squared0.12
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Artrya Limited News
PremiumCompany Announcements
Artrya Set for FDA Submission of Salix Product
PremiumCompany Announcements
Artrya Advances on FDA Approval and Strategic US Partnerships
PremiumCompany Announcements
Artrya Limited Issues Equity for Employee IncentivesPremiumCompany Announcements
Artrya Limited Issues New Unlisted Options
PremiumCompany Announcements
Artrya Limited Announces New Security Issue
PremiumCompany Announcements
Artrya Limited Secures Key U.S. Partnership
PremiumCompany Announcements
Artrya Advances Toward FDA ApprovalPremiumCompany Announcements
Artrya Expands Global Footprint in Heart Disease AIOptions Prices
Currently, No data available
---
Ownership Overview
14.60% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
85.40% Public Companies and
Individual Investors
AYA FAQ
What was Artrya Limited’s price range in the past 12 months?
Artrya Limited lowest share price was AU$0.16 and its highest was AU$0.42 in the past 12 months.
What is Artrya Limited’s market cap?
Currently, no data Available
When is Artrya Limited’s upcoming earnings report date?
Artrya Limited’s upcoming earnings report date is Feb 25, 2025 which is in 170 days.
How were Artrya Limited’s earnings last quarter?
Artrya Limited released its earnings results on Aug 29, 2024. The company reported -AU$0.09 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.09.
Is Artrya Limited overvalued?
According to Wall Street analysts Artrya Limited’s price is currently Overvalued.
Does Artrya Limited pay dividends?
Artrya Limited does not currently pay dividends.
What is Artrya Limited’s EPS estimate?
Artrya Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Artrya Limited have?
Artrya Limited has 78,703,995 shares outstanding.
What happened to Artrya Limited’s price movement after its last earnings report?
Artrya Limited reported an EPS of -AU$0.09 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.375%.
Which hedge fund is a major shareholder of Artrya Limited?
Currently, no hedge funds are holding shares in AU:AYA
---
Artrya Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.72%
12-Months-Change
Fundamentals
Return on Equity
-59.12%
Trailing 12-Months
Asset Growth
-42.54%
Trailing 12-Months
Company Description
Artrya Limited
Artrya Ltd is a medical technology company engaged in developing software that automates the analysis of heart computed tomography (CT) scans to assist in the diagnosis of Coronary Artery Disease.
---
Technical Analysis
---